Monness Crespi Hardt & Co. has raised its price target on Meta Platforms from $730 to $830, citing the popularity of its Muse AI agent product.

Analyst Brian White wrote that "for much of 2026, Meta has struggled to provide investors with concrete evidence that its massive capital expenditure plans and the hefty compensation packages at Meta Superintelligence Labs are strengthening the company's position in the AI race," but "the early progress of Muse, along with the personal AI agent vision Meta unveiled last week, has shifted the market narrative in the company's favor."

The "Buy" rating was maintained; White believes that over the long term, Meta shares "should command a valuation premium relative to the broader market and the tech sector."

Meta fell 2.9% in premarket trading; the stock has gained more than 30% this month.